邮件订阅 RSS

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

我国高血压预防与诊疗模式的建议

孙英贤

downloadPDF
文章导航 > 协和医学杂志  > 2019 >  10(2): 97-99
孙英贤. 我国高血压预防与诊疗模式的建议[J]. 协和医学杂志, 2019, 10(2): 97-99. doi: 10.3969/j.issn.1674-9081.2019.02.001
引用本文: 孙英贤. 我国高血压预防与诊疗模式的建议[J]. 协和医学杂志, 2019, 10(2): 97-99. doi: 10.3969/j.issn.1674-9081.2019.02.001
shu
Ying-xian SUN. Suggestion on China Mode of Prevention, Diagnosis and Treatment of Hypertension[J]. Medical Journal of Peking Union Medical College Hospital, 2019, 10(2): 97-99. doi: 10.3969/j.issn.1674-9081.2019.02.001
Citation: Ying-xian SUN. Suggestion on China Mode of Prevention, Diagnosis and Treatment of Hypertension[J]. Medical Journal of Peking Union Medical College Hospital, 2019, 10(2): 97-99. doi: 10.3969/j.issn.1674-9081.2019.02.001
shu

我国高血压预防与诊疗模式的建议

doi: 10.3969/j.issn.1674-9081.2019.02.001

  • 中国医科大学附属第一医院心内科，沈阳 110001

详细信息
    作者简介:

    孙英贤：电话：024-83283166，E-mail：yxsun@cmu.edu.cn

  • 中图分类号: R544.1

Suggestion on China Mode of Prevention, Diagnosis and Treatment of Hypertension

  • Department of Cardiology, The First Hospital of China Medical University, Shenyang 110001, China

More Information

    摘要
  • 摘要: 高血压在全球和我国均是第一大慢性疾病，其心脑血管疾病并发症是我国居民首位死亡原因。近年来，国外研究多提示以社区为基础的高血压预防与诊疗模式是提高其控制率的有效途径。我国在20世纪开展的社区干预研究，以健康教育为主，虽取得了显著成果，但始终未能在全国范围内推广。进入21世纪后，我国在高血压预防与诊疗模式方面也进行了相关研究，但目前高血压管理仍存在诸多不足，故应积极探索适合我国国情的预防和诊疗模式，以提高高血压控制率。
    Abstract: Hypertension is the top chronic disease in both the world and China, and its complications of cardiovascular and cerebrovascular diseases are the leading cause of death in our country. Recently, plenty of foreign researches have suggested that the community-based mode of the prevention and treatment of hypertension is an effective way to improve the control rate. In the 20th century, China conducted research on community intervention, focusing on health education, which have achieved remarkable results but not been widely promoted. Since the beginning of the 21st century, China has also carried out many studies on the prevention and treatment of hypertension. However, there are still many shortcomings in the management of hypertension. Therefore, to improve the control rate of hypertension in China, we should actively explore the modes of prevention and treatment suitable for China's national condition.
    利益冲突  无
    • HTML全文
    • 参考文献(14)
  • [1] Gao Y, Chen G, Tian H, et al. Prevalence of hypertension in china: a cross-sectional study[J]. PLoS One, 2013, 8:e65938. http://europepmc.org/articles/PMC3679057
    [2] Wang J, Zhang L, Wang F, et al. Prevalence, awareness, treatment, and control of hypertension in China: results from a national survey[J]. Am J Hypertens, 2014, 27:1355-1361. doi:  10.1093/ajh/hpu053
    [3] 李镒冲, 王丽敏, 姜勇, 等.2010年中国成年人高血压患病情况[J].中华预防医学杂志, 2012, 46:409-413. doi:  10.3760/cma.j.issn.0253-9624.2012.05.007
    [4] Xu Y, Bi Y, Li M, et al.Prevalence, Awareness, Treatment, and Control of Hypertension in China: The China Metabolic Risk Factor Study[J]. Circulation, 2013, 127:A005. http://www.researchgate.net/publication/293476359_Prevalence_Awareness_Treatment_and_Control_of_Hypertension_in_China_The_China_Metabolic_Risk_Factor_Study
    [5] Li W, Gu H, Teo KK, et al.Hypertension prevalence, awareness, treatment, and control in 115 rural and urban communities involving 47 000 people from China[J]. J Hypertens, 2016, 34:39-46. doi:  10.1097/HJH.0000000000000745
    [6] Li Z, Guo X, Zheng L, et al. Grim status of hypertension in rural China: results from Northeast China Rural Cardio-vascular Health Study 2013[J]. J Am Soc Hypertens, 2015, 9:358-364. doi:  10.1016/j.jash.2015.02.014
    [7] Lu J, Lu Y, Wang X, et al.Prevalence, awareness, treatment, and control of hypertension in China: data from 1.7 million adults in a population-based screening study (China PEACE Million Persons Project)[J]. Lancet, 2017, 390:2549-2558. doi:  10.1016/S0140-6736(17)32478-9
    [8] Su M, Zhang Q, Bai X, et al.Availability, cost, and prescription patterns of antihypertensive medications in primary health care in China: a nationwide cross-sectional survey[J]. Lancet, 2017, 390:2559-2568. doi:  10.1016/S0140-6736(17)32476-5
    [9] Nissinen A, Tuomilehto J, Elo J, et al. Implementation of a hypertension control program in the county of North Karelia, Finland[J]. Public Health Rep, 1981, 96:503-513. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=PubMed000001227664
    [10] Fortmann SP, Winkleby MA, Flora JA, et al. Effect of long-term community health education on blood pressure and hypertension control. The Stanford Five-City Project[J]. Am J Epidemiol, 1990, 132:629-646. doi:  10.1093/oxfordjournals.aje.a115705
    [11] He J, Irazola V, Mills KT, et al.HCPIA Investigators. Effect of a Community Health Worker-Led Multicomponent Intervention on Blood Pressure Control in Low-Income Patients in Argentina: A Randomized Clinical Trial[J]. JAMA, 2017, 318:1016-1025. doi:  10.1001/jama.2017.11358
    [12] Victor RG, Lynch K, Li N, et al.A Cluster-Randomized Trial of Blood-Pressure Reduction in Black Barbershops[J]. N Engl J Med, 2018, 378:1291-1301. doi:  10.1056/NEJMoa1717250
    [13] Tian M, Ajay VS, Dunzhu D, et al. A Cluster-Randomized, Controlled Trial of a Simplified Multifaceted Management Program for Individuals at High Cardiovascular Risk (SimCard Trial) in Rural Tibet, China, and Haryana, India[J]. Circulation, 2015, 132:815-824. doi:  10.1161/CIRCULATIONAHA.115.015373
    [14] 《中国高血压防治指南》修订委员会.中国高血压防治指南2018年修订版[J].心脑血管病防治, 2019, 19:1-45. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=xnxgbfz201901001
    • 相关文章
    • 施引文献
  • 资源附件(0)
  • 加载中
WeChat 点击查看大图
计量
  • 文章访问数:  517
  • HTML全文浏览量:  28
  • PDF下载量:  556
  • 被引次数: 0
出版历程
  • 收稿日期:  2018-12-20
  • 刊出日期:  2019-03-01

目录

    /

    返回文章
    返回
    友情链接: 国家卫生健康委员会 北京协和医院 中国医学科学院 学术不端检测系统 国际知识资源总库 中国知网 术语在线 中国全科医学
    地址：北京市东城区帅府园1号 北京协和医院老楼7号楼
    3层302室 《协和医学杂志》编辑部
    电话：010-69154261/4262
    E - mail：medj@pumch.cn
    mjpumch@126.com
    期刊网站版权所有：《协和医学杂志》编辑部
    京ICP备 11002662

    本系统由 北京仁和汇智信息技术有限公司 开发    百度统计

    x 关闭 永久关闭

    【温馨提醒】近日，《协和医学杂志》编辑部接到作者反映，有多名不法人员冒充期刊编辑发送见刊通知，鼓动作者添加微信，从而骗取版面费的行为。特提醒您，本刊与作者联系的方式均为邮件通知或电话，稿件进度通知邮箱为：mjpumch@126.com，编辑部电话为：010-69154261，请提高警惕，谨防上当受骗！如有任何疑问，请致电编辑部核实。谢谢！